None listed
Conditions
Brief summary
This is an expanded access designed to provide access to Bromodomain and Extra-Terminal (BET) Inhibitor for eligible participants.
Interventions
DRUGBET Inhibitor
Bromodomain and Extra-Terminal Inhibitor
Sponsors
Bristol-Myers Squibb
Eligibility
Outcome results
None listed